The activity of TRPC1 is higher in dystrophic myotubes from mdx mice and human DMD patients, and TRPC1 is responsible for the increased Ca2+ entry in mdx myotubes compared with control myotubes [38,98,99,100,101]. This evidence concerns the gene TRPC1 and Duchenne muscular dystrophy.